Septerna (SEPN) Earnings Date & Reports

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SEPN is expected to report earnings to fall 500.00% to -72 cents per share on March 26

Q4'25

Est.

$-0.72

Q3'25

Beat

by $0.83

Q2'25

Beat

by $0.07

Q1'25

Beat

by $0.05

The last earnings report on November 10 showed earnings per share of 18 cents, beating the estimate of -64 cents. With 65.75K shares outstanding, the current market capitalization sits at 1.12B.

View a ticker or compare two or three

Compare

SEPN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SEPN showed earnings on November 10, 2025. You can read more about the earnings report here.

View AI-Driven Trading for SEPN

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details